BCL2L1 and neoplasm: The results showed that the expression of drug resistance proteins MRP1 and P-gp, anti-apoptotic proteins Bcl-2, and Bcl-xL decreased after treatment with DHTS in HCT116/OXA cells and tumor tissues.